These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8846622)

  • 21. A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.
    Sim SC; Risinger C; Dahl ML; Aklillu E; Christensen M; Bertilsson L; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2006 Jan; 79(1):103-13. PubMed ID: 16413245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human cytochrome P450-catalyzed conversion of the proestrogenic pesticide methoxychlor into an estrogen. Role of CYP2C19 and CYP1A2 in O-demethylation.
    Stresser DM; Kupfer D
    Drug Metab Dispos; 1998 Sep; 26(9):868-74. PubMed ID: 9733665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of St John's Wort on CYP2C19 activity with respect to genotype.
    Wang LS; Zhu B; Abd El-Aty AM; Zhou G; Li Z; Wu J; Chen GL; Liu J; Tang ZR; An W; Li Q; Wang D; Zhou HH
    J Clin Pharmacol; 2004 Jun; 44(6):577-81. PubMed ID: 15145964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro modulatory effects of Andrographis paniculata, Centella asiatica and Orthosiphon stamineus on cytochrome P450 2C19 (CYP2C19).
    Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
    J Ethnopharmacol; 2011 Jan; 133(2):881-7. PubMed ID: 21093571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
    Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
    Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin.
    Ferguson RJ; De Morais SM; Benhamou S; Bouchardy C; Blaisdell J; Ibeanu G; Wilkinson GR; Sarich TC; Wright JM; Dayer P; Goldstein JA
    J Pharmacol Exp Ther; 1998 Jan; 284(1):356-61. PubMed ID: 9435198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6.
    Mankowski DC
    Drug Metab Dispos; 1999 Sep; 27(9):1024-8. PubMed ID: 10460802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics.
    Ishizawa Y; Yasui-Furukori N; Takahata T; Sasaki M; Tateishi T
    Clin Pharmacokinet; 2005; 44(11):1179-89. PubMed ID: 16231968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sinomenine on human cytochrome P450 activity.
    Yao YM; Cao W; Cao YJ; Cheng ZN; Ou-Yang DS; Liu ZQ; Zhou HH
    Clin Chim Acta; 2007 Apr; 379(1-2):113-8. PubMed ID: 17292874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug interactions with proton pump inhibitors.
    Unge P; Andersson T
    Drug Saf; 1997 Mar; 16(3):171-9. PubMed ID: 9098655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets.
    Uehara S; Kawano M; Murayama N; Uno Y; Utoh M; Inoue T; Sasaki E; Yamazaki H
    Biochem Pharmacol; 2016 Nov; 120():56-62. PubMed ID: 27641812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of monkey cytochrome P450, P450 CMLd, responsible for S-mephenytoin 4-hydroxylation in hepatic microsomes of cynomolgus monkeys.
    Ohmori S; Chiba K; Nakasa H; Horie T; Kitada M
    Arch Biochem Biophys; 1994 Jun; 311(2):395-401. PubMed ID: 8203903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Assessment of Cytochrome P450 2C19 Potential of Naoxintong.
    Chen H; Zhang Y; Wu X; Li C; Wang H
    Evid Based Complement Alternat Med; 2012; 2012():430262. PubMed ID: 22454664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro data.
    Isoherranen N; Lutz JD; Chung SP; Hachad H; Levy RH; Ragueneau-Majlessi I
    Chem Res Toxicol; 2012 Nov; 25(11):2285-300. PubMed ID: 22823924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian Genetics of Depression Study.
    Campos AI; Byrne EM; Mitchell BL; Wray NR; Lind PA; Licinio J; Medland SE; Martin NG; Hickie IB; Rentería ME
    Pharmacogenomics J; 2022 Mar; 22(2):130-135. PubMed ID: 35094016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450 interactions are common and consequential in Massachusetts hospital discharges.
    McCoy TH; Castro VM; Cagan A; Snapper L; Roberson A; Perlis RH
    Pharmacogenomics J; 2018 Apr; 18(2):347-350. PubMed ID: 28696416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Relevance of CYP2D6 Polymorphisms in Patients of an Austrian Medical Practice: A Family Practice-Based Observational Study.
    Kamenski G; Ayazseven S; Berndt A; Fink W; Kamenski L; Zehetmayer S; Pühringer H
    Drugs Real World Outcomes; 2020 Mar; 7(1):63-73. PubMed ID: 31863305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of changes in cytochrome P450 2C19 activity in type 2 diabetic rats before and after treatment, by using isolated perfused liver model.
    Neyshaburinezhad N; Rouini MR; Entezari H; Lavasani H; Hosseinzadeh Ardakani Y
    Iran J Basic Med Sci; 2020 May; 23(5):629-635. PubMed ID: 32742601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why bother about cytochrome P450 enzymes?
    Drug Ther Bull; 2000 Dec; 38(12):93-5. PubMed ID: 11221185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive
    Seo ME; Min BJ; Heo N; Lee KH; Kim JH
    Front Pharmacol; 2023; 14():1055991. PubMed ID: 36713839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.